1)Renner P, Milazzo S, Liu JP, et al:Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients. Cochrane Database Syst Rev 10:CD007913, 2012
2)Gornik HL, Creager MA:Aortitis. Circulation 117:3039-3051, 2008
3)Bossone E, Pluchinotta FR, Andreas M, et al:Aortitis. Vascul Pharmacol 80:1-10, 2016
4)Saadoun D, Vautier M, Cacoub P:Medium- and large-vessel vasculitis. Circulation 143:267-282, 2021
5)Sato Y, Kaji S, Ueda H, et al:Thoracic aortitis and aortic dissection following pegfilgrastim administration. Eur J Cardiothorac Surg 52:993-994, 2017
6)Franzke A, Piao W, Lauber J, et al:G-CSF as immune regulator in T cells expressing the G-CSF receptor:implications for transplantation and autoimmune diseases. Blood 102:734-739, 2003
7)医薬品医療機器総合機構:医薬品・医療機器等安全性情報No. 354.2 重要な副作用等に関する情報.2018年6月. https://www.pmda.go.jp/files/000224762.pdf#page=9(2024年4月1日アクセス)
8)Lardieri A, McCulley L, Jones SC, et al:Granulocyte colony-stimulating factors and aortitis:a rare adverse event. Am J Hematol 93:E333-E336, 2018
9)Oshima Y, Takahashi S, Tani K, et al:Granulocyte colony-stimulating factor-associated aortitis in the Japanese Adverse Drug Event Report database. Cytokine 119:47-51, 2019
10)Lee SY, Kim EK, Kim JY, et al:The incidence and clinical features of PEGylated filgrastim-induced acute aortitis in patients with breast cancer. Sci Rep 10:18647, 2020
11)矢野良一:がん化学療法による好中球減少症のリスクファクターに関する研究.医療薬40:317-333,2014
12)Corral de la Fuente E, Barquín Garcia A, Saavedra Serrano C, et al:Myocarditis and carotidynia caused by Granulocyte-Colony stimulating factor administration. Mod Rheumatol Case Rep 4:318-323, 2020
13)Schuetz P, Albrich W, Mueller B:Procalcitonin for diagnosis of infection and guide to antibiotic decisions:past, present and future. BMC Med 9:107, 2011
14)Saito H, Suda T, Oishi N, et al:Pegfilgrastim-induced large vessel vasculitis. BMJ Case 14:e243757, 2021
15)Carstanjen D, Regenfus M, Müller C, et al:Interleukin-6 is a major effector molecule of short-term G-CSF treatment inducing bone metabolism and an acute-phase response. Exp Hematol 29:812-821, 2001
16)Hoshina H, Takei H:Granulocyte-colony stimulating factor-associated aortitis in a woman with advanced breast cancer:a case report and review of the literature. BMC Cancer 19:1217, 2019
17)Koyama Y, Adachi K, Yagi M, et al:Successful treatment of G-CSF-related aortitis with prednisolone during preoperative chemotherapy for breast cancer:a case report. Surg Case Rep 7:23, 2021
18)池田裕里恵,奥泉 譲,木原好則,他:G-CSF製剤投与後に発症した大型血管炎6例の画像的検討.新潟中病医会誌27:10-13,2019
19)Taimen K, Heino S, Kohonen I, et al:Granulocyte colony-stimulating factor- and chemotherapy-induced large-vessel vasculitis:six patient cases and a systematic literature review.Rheumatol Adv Pract 4:rkaa004, 2020
20)Soussan M, Nicolas P, Schramm C, et al:Management of large-vessel vasculitis with FDG-PET:a systematic literature review and metaanalysis. Medicine(Baltimore)94:e622, 2015
21)Harada M, Motoki H, Sakai T, et al:Granulocyte colony stimulating factor-associated aortitis evaluated via multiple imaging modalities including vascular echography:a case report.Eur Heart J Case Rep 5:ytaa503, 2020
22)Nakov R, Gattu S, Wang J, et al:Proposed biosimilar pegfilgrastim shows similarity in pharmacokinetics and pharmacodynamics to reference pegfilgrastim in healthy subjects. Br J Clin Pharmacol 84:2790-2801, 2018
23)日本循環器学会,日本医学放射線学会,日本眼科学会他(班長:磯部光章):血管炎症候群の診療ガイドライン(2017年改訂版).2018. http://www.jcirc.or.jp/guideline/pdf/JCS2017_isobe_h.pdf(2024年4月1日アクセス)
24)Shiraki E, Hamada-Nishimoto M, Kang Y, et al:Aortitis and aortic dissection after administration of pegfilgrastim during adjuvant chemotherapy for early breast cancer. Int Cancer Conf J 11:138-141, 2022
25)Fujiwara Y, Yamaguchi T, Nakane M:Granulocyte colony-stimulating factor-associated aortitis:treatment suggestion for this complication. JCO Oncol Pract 17:57-58, 2021
26)Yamamoto S, Waki D, Maeda T:Granulocyte-colony stimulating factor-induced vasculitis successfully treated with short-term corticosteroid therapy:a case report. Cureus 13:e20563, 2021
27)Seto Y, Kittaka N, Taniguchi A, et al:Pegfilgrastim-induced vasculitis of the subclavian and basilar artery complicated by subarachnoid hemorrhage in a breast cancer patient:a case report and review of the literature. Surg Case Rep 8:155, 2022
28)千野辰徳,大場崇旦,山本佳那,他:乳癌化学療法中Pegfilgrastim投与後に動脈炎所見を認めた1例.癌と化療45:1771-1774,2018